Answers are grounded in this paper and cite their sources.
Inflammatory arthropathies (IAs) are a group of chronic autoimmune diseases that most commonly affect women of childbearing age. Etanercept is an anti-TNF drug that has been shown to be effective in treating IA patients; however, there is limited data on its safety in pregnant women, especially in Asian countries. This study aimed to evaluate the pregnancy and neonatal outcomes in pregnant patients with IA receiving etanercept. In the present retrospective study, the records of patients with IAs
No takes yet. Share an insight, caveat, or question.
Mohammadi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: